Bewersdorf JP, Patel KK, Goshua G, Shallis RM, et al. Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with IDH1-mutant acute myeloid leukemia. Leuk Lymphoma 2022 Dec 9:1-8. doi: 10.1080/10428194.2022.2140288.
PMID: 36493798